AMPHOTERICIN B
ANTIFUNGALS-SYSTEMIC·FUNGAL SEPSIS·+22
X-GEN PHARMACEU
Indication
Rhinocerebral phycomycosis
Rhinocerebral phycomycosis—more commonly termed rhinocerebral mucormycosis or zygomycosis—is a rare, aggressive, and often life-threatening opportunistic fungal infection involving the paranasal sinuses, orbits, and central nervous system. Read more about Rhinocerebral phycomycosis
3 drugs 3 manufacturers
Drugs that treat it
Common Rhinocerebral phycomycosis therapies.
ABELCET (amphotericin B lipid complex)
FUNGAL SEPSIS·+22
SIGMA-TAU
ABELCET (amphotericin B lipid complex)
FUNGAL SEPSIS·+22
SIGMA-TAU/LEADI
Filter & compare in the drug finder →Opens the drug finder with Rhinocerebral phycomycosis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRhinocerebral phycomycosis—more commonly termed rhinocerebral mucormycosis or zygomycosis—is a rare, aggressive, and often life-threatening opportunistic fungal infection involving the paranasal sinuses, orbits, and central nervous system.
It primarily affects immunocompromised individuals, most notably patients with uncontrolled diabetes mellitus presenting with ketoacidosis, prolonged neutropenia, hematologic malignancies, or immunosuppressive therapy.
Pathophysiologically, ubiquitous environmental molds belonging to the order Mucorales (such as *Rhizopus* and *Mucor* species) invade the nasal mucosa and demonstrate marked angioinvasion, producing vascular thrombosis, extensive tissue necrosis, and hallmark black necrotic eschars with rapid contiguous intracranial extension.
- nih.gov
Rhinocerebral phycomycosis—more commonly termed rhinocerebral mucormycosis or zygomycosis—is a rare, aggressive, and often life-threatening opportunistic fungal infection involving the paranasal sinuses, orbits, and central nervous system
- nih.gov
Rhinocerebral phycomycosis—more commonly termed rhinocerebral mucormycosis or zygomycosis—is a rare, aggressive, and often life-threatening opportunistic fungal infection involving the paranasal sinuses, orbits, and central nervous system It primarily affects immunocompromised individuals, most notably patients with uncontrolled diabetes mellitus presenting with ketoacidosis, prolonged neutropenia, hematologic malignancies, or immunosuppressive therapy Pathophysiologically, ubiquitous environmen...
- nih.gov
It primarily affects immunocompromised individuals, most notably patients with uncontrolled diabetes mellitus presenting with ketoacidosis, prolonged neutropenia, hematologic malignancies, or immunosuppressive therapy Pathophysiologically, ubiquitous environmental molds belonging to the order Mucorales (such as *Rhizopus* and *Mucor* species) invade the nasal mucosa and demonstrate marked angioinvasion, producing vascular thrombosis, extensive tissue necrosis, and hallmark black necrotic eschars...
- news-medical.net
It primarily affects immunocompromised individuals, most notably patients with uncontrolled diabetes mellitus presenting with ketoacidosis, prolonged neutropenia, hematologic malignancies, or immunosuppressive therapy
- nih.gov
Pathophysiologically, ubiquitous environmental molds belonging to the order Mucorales (such as *Rhizopus* and *Mucor* species) invade the nasal mucosa and demonstrate marked angioinvasion, producing vascular thrombosis, extensive tissue necrosis, and hallmark black necrotic eschars with rapid contiguous intracranial extension
- oup.com
Pathophysiologically, ubiquitous environmental molds belonging to the order Mucorales (such as *Rhizopus* and *Mucor* species) invade the nasal mucosa and demonstrate marked angioinvasion, producing vascular thrombosis, extensive tissue necrosis, and hallmark black necrotic eschars with rapid contiguous intracranial extension
Personalize your experience
Follow Rhinocerebral phycomycosis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.